Cell and gene therapies are revolutionizing next-generation therapeutics. Many researchers are now leveraging the power of CRISPR precision genome engineering in their cell and gene therapies research, from fixing mutations associated with disease to modifying immune cells to attack cancer.

In this webinar, brought to you by Synthego, cell and gene therapy experts will discuss the applications of CRISPR in studying genetic diseases and beyond.


Bruce Conklin, MD
Senior Investigator, Gladstone Institutes, Deputy Director, Innovative Genomics Institute, Professor, Departments of Medicine, Pharmacology, and Ophthalmology, University of California, San Francisco

Robert Deans, PhD
Chief Scientific Officer, Synthego